Carrasco, Kevin
Boufenzer, Amir
Jolly, Lucie
Le Cordier, Helene
Wang, Guanbo
Heck, Albert JR
Cerwenka, Adelheid
Vinolo, Emilie
Nazabal, Alexis
Kriznik, Alexandre
Launay, Pierre
Gibot, Sebastien
Derive, Marc
Article History
Received: 31 July 2017
Revised: 1 January 2018
Accepted: 9 January 2018
First Online: 22 March 2018
<!--Emphasis Type='Bold' removed-->Competing interests
: M.D. and S.G. are co-founders of Inotrem SA, a Company developing TREM-1 inhibitors. P.L. is co-founder of Inatherys SA, a Company developing therapeutic monoclonal antibodies. A.N. is co-founder of CovalX GmbH, a Company providing services for the analysis of protein complexes. The remaining authors declare that they have no competing interests.